Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma

Glaucoma is a leading cause of blindness worldwide. In glaucoma, a progressive dysfunction and death of retinal ganglion cells occurs, eliminating transfer of visual information to the brain. Currently, the only available therapies target the lowering of intraocular pressure, but many patients conti...

Full description

Bibliographic Details
Main Authors: James R. Tribble, Flora Hui, Melissa Jöe, Katharina Bell, Vicki Chrysostomou, Jonathan G. Crowston, Pete A. Williams
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cells
Subjects:
NAD
Online Access:https://www.mdpi.com/2073-4409/10/2/295
id doaj-1b68f454598f428cbf402e0c99468f00
record_format Article
spelling doaj-1b68f454598f428cbf402e0c99468f002021-02-02T00:04:14ZengMDPI AGCells2073-44092021-02-011029529510.3390/cells10020295Targeting Diet and Exercise for Neuroprotection and Neurorecovery in GlaucomaJames R. Tribble0Flora Hui1Melissa Jöe2Katharina Bell3Vicki Chrysostomou4Jonathan G. Crowston5Pete A. Williams6Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, 171 64 Stockholm, SwedenCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC 3002, AustraliaDepartment of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, 171 64 Stockholm, SwedenSingapore Eye Research Institute, Singapore National Eye Centre, Singapore 168751, SingaporeSingapore Eye Research Institute, Singapore National Eye Centre, Singapore 168751, SingaporeCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC 3002, AustraliaDepartment of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, 171 64 Stockholm, SwedenGlaucoma is a leading cause of blindness worldwide. In glaucoma, a progressive dysfunction and death of retinal ganglion cells occurs, eliminating transfer of visual information to the brain. Currently, the only available therapies target the lowering of intraocular pressure, but many patients continue to lose vision. Emerging pre-clinical and clinical evidence suggests that metabolic deficiencies and defects may play an important role in glaucoma pathophysiology. While pre-clinical studies in animal models have begun to mechanistically uncover these metabolic changes, some existing clinical evidence already points to potential benefits in maintaining metabolic fitness. Modifying diet and exercise can be implemented by patients as an adjunct to intraocular pressure lowering, which may be of therapeutic benefit to retinal ganglion cells in glaucoma.https://www.mdpi.com/2073-4409/10/2/295glaucomaoptic nerveretinal ganglion cellsdietexerciseNAD
collection DOAJ
language English
format Article
sources DOAJ
author James R. Tribble
Flora Hui
Melissa Jöe
Katharina Bell
Vicki Chrysostomou
Jonathan G. Crowston
Pete A. Williams
spellingShingle James R. Tribble
Flora Hui
Melissa Jöe
Katharina Bell
Vicki Chrysostomou
Jonathan G. Crowston
Pete A. Williams
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Cells
glaucoma
optic nerve
retinal ganglion cells
diet
exercise
NAD
author_facet James R. Tribble
Flora Hui
Melissa Jöe
Katharina Bell
Vicki Chrysostomou
Jonathan G. Crowston
Pete A. Williams
author_sort James R. Tribble
title Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
title_short Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
title_full Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
title_fullStr Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
title_full_unstemmed Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
title_sort targeting diet and exercise for neuroprotection and neurorecovery in glaucoma
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2021-02-01
description Glaucoma is a leading cause of blindness worldwide. In glaucoma, a progressive dysfunction and death of retinal ganglion cells occurs, eliminating transfer of visual information to the brain. Currently, the only available therapies target the lowering of intraocular pressure, but many patients continue to lose vision. Emerging pre-clinical and clinical evidence suggests that metabolic deficiencies and defects may play an important role in glaucoma pathophysiology. While pre-clinical studies in animal models have begun to mechanistically uncover these metabolic changes, some existing clinical evidence already points to potential benefits in maintaining metabolic fitness. Modifying diet and exercise can be implemented by patients as an adjunct to intraocular pressure lowering, which may be of therapeutic benefit to retinal ganglion cells in glaucoma.
topic glaucoma
optic nerve
retinal ganglion cells
diet
exercise
NAD
url https://www.mdpi.com/2073-4409/10/2/295
work_keys_str_mv AT jamesrtribble targetingdietandexerciseforneuroprotectionandneurorecoveryinglaucoma
AT florahui targetingdietandexerciseforneuroprotectionandneurorecoveryinglaucoma
AT melissajoe targetingdietandexerciseforneuroprotectionandneurorecoveryinglaucoma
AT katharinabell targetingdietandexerciseforneuroprotectionandneurorecoveryinglaucoma
AT vickichrysostomou targetingdietandexerciseforneuroprotectionandneurorecoveryinglaucoma
AT jonathangcrowston targetingdietandexerciseforneuroprotectionandneurorecoveryinglaucoma
AT peteawilliams targetingdietandexerciseforneuroprotectionandneurorecoveryinglaucoma
_version_ 1724314675389136896